An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to message these profiles privately for source information, while also obtaining discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, physicians and chemists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.
Some professionals said the popularity for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Service Response and Material Removal
According to TikTok, the service has taken down violative material and banned associated hashtags and search suggestions. The organization stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.
Online Marketplace Activities
Investigations also found communities with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.
After minutes of entering one group, a seller shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, medical conditions or past usage.
Item Details and Costs
Within these communities, posts display dark colored parcels with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how much time a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is valid, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has already seen patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may subject patients to potentially significant medical dangers”.
